🏅 FDA Orphan Designation
Cyfendus
Anthrax Vaccine Adsorbed, Adjuvanted
Manufacturer: Emergent Product Development Gaithersburg, Inc.
Indicated for:
FDA-Approved Indications (1)
OBSOLETE: Disease predisposing to age-related macular degenerationOrphan Designation
post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacteri…
Indications & Usage
post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.